About this raise: Thrivelab, with a valuation of $17.25 million, is raising funds on Wefunder. The company has developed a concierge hormone health program to help people with hormonal imbalances. The platform offers self-assessment for patients to onboard, followed by an initial consult and a patent-pending blend of treatment protocols, nutraceuticals, and technology. Thrivelab is led by an experienced team and generated a 558% revenue growth in 2022. Joshua Host, Dr. Nayan Patel, Dr. Ryan Jones, and Rahula Kocher founded Thrivelab in July 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1 million. The campaign proceeds will be used for increasing ad spending, launching new marketing channels, and IT team development.
Investment Overview
Invested : $108,590
Deal Terms
Total Commitments ($USD)
- Platform
- Wefunder
- Start Date
- 02/01/2023
- Close Date
- 04/30/2023
$50,000
$1,000,000
$100
SAFE
Seed
RegCF
$13,000,000
$17,250,000
20%
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- Low
Financials
-
Revenue
- $193,662
- Monthly Burn
- $79,260
-
Runway
- 1.6 months
- Gross Margin
- 51%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $1,026,919
- VC Backed?
- No
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.